The short answer
Measure international patient acquisition from inquiry through qualified consultation, booking, visit, aftercare, and contribution revenue—not by clicks alone. Aggregate market data does not prove provider-level demand or profitability, and patient or health data must not enter analytics or advertising platforms.
KHIDI's analysis of 2024 card spending reports KRW 279.6 billion in Korean medical-category card spending by foreign patients from Japan. This is aggregate evidence of spending in Korea's inbound medical market; it does not establish demand, ranking, acquisition cost, or profitability for any individual provider.
Define the measurement path as source → localized information → inquiry → qualified consultation → booking → visit or treatment → cancellation and aftercare → contribution revenue. Record an owner, timestamp, status, and next action at each stage so the team can identify where progression stops.
Before increasing media spend, verify localized service information, price and cancellation guidance, an inquiry owner, appointment capacity, arrival instructions, and aftercare responsibility. If inquiries do not progress to qualified consultations, bookings, and visits, diagnose demand, message, response, or operating constraints first.
Do not send symptoms, procedure names, consultation details, or other patient and health data to analytics or advertising platforms. Use anonymized funnel identifiers and aggregate events; keep operational patient records in an approved system with separated access controls.
The client's responsible owner or designated specialist must review applicable patient-attraction and medical-advertising requirements. RIVACTA does not provide legal or medical determinations or regulatory approval. A Fit Call is a pre-contract fit check with no research, strategy, or deliverable; journey and measurement work begins only after a paid Market Diagnostic agreement.